Is artificial intelligence a friend or foe to epidemiology?

人工智能对流行病学来说是朋友还是敌人?

阅读:1

Abstract

Epidemiology has long been central to public health, guiding our understanding of the distribution and determinants of disease. As the field has evolved-from John Snow's cholera investigations to large-scale cohort studies and causal inference frameworks-it now faces a transformative juncture with the advent of artificial intelligence/machine learning (AI/ML). These technologies offer unprecedented opportunities to improve data measurement, inference, and population health insights, yet also pose methodological and ethical challenges. Anchored by the core epidemiologic domains of study population, measurement, and inference, we examine how epidemiologists can use AI/ML effectively. We consider the importance of careful population definition, informed sampling, and external validation to ensure generalizability and minimize bias when AI/ML is used. We also explore the need for rigorous assessment of data quality and model reliability, which strengthens the case for conceptual frameworks in guiding interpretation of scientific investigations. To realize AI/ML's potential, epidemiology must adapt its training, invest in infrastructure, and promote interdisciplinary collaboration. Doing so will ensure that epidemiologic science remains robust, reproducible, and relevant in a rapidly evolving informational landscape. This moment calls for a strategic integration of AI/ML into the fabric of epidemiologic practice and training to advance both science and public health.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。